BioCryst Pharmaceuticals Inc. / MPH / M.D. Principal Deputy / /
Country
United States / /
Event
FDA Phase / Person Communication and Meetings / /
IndustryTerm
certain in vitro diagnostic devices / zanamivir products / authorized zanamivir products / manufacturing practice / peramivir product / local law / above peramivir product / manufacturing / online internet access such reports / /
MedicalCondition
H1N1 infection / Swine Influenza A / systemic illness / H1N1 influenza virus / illness / MS / influenza / H1N1 Influenza A / nonsubtypable influenza A / serious bronchospasm / asthma / severe allergic reaction / Disease / chronic obstructive pulmonary disease / Influenza A / H1N1 flu / renal insufficiency / Influenza viruses / infection / involving Swine Influenza A / /
National Institute of Health / Centers for Disease Control and Prevention Advisory Committee on Immunization Practices / Availability AGENCY / Centers for Disease Control and Prevention / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / FDA / DEPARTMENT OF HEALTH AND HUMAN SERVICES Authorization of Emergency Use of Certain In Vitro Diagnostic Devices / Department of Health and Human Services / office of Counterterrorism and Emerging Threats / /
Person
Boris Lushniak / Joshua M. Sharfstein / Fact Sheet / Thomas R. Frieden / Leslie Kux / / /
Position
Secretary of Health / Secretary / Governor / Acting Secretary / Director / Commissioner / Acting Assistant Commissioner for Policy / /
Product
Peramivir injection / peramivir / /
ProvinceOrState
Maryland / Georgia / /
Technology
pdf / in vitro diagnostics / drug delivery / http / /
Federal Register / Vol. 75, No[removed]Monday, April 19, [removed]Notices[removed]Zanamivir products are not recommended for treatment or prophylaxis of influenza in individuals with underlying airways disease (such as asth